Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis

OBJECTIVE: To assess the effects of treatment with antitumour necrosis factor (TNF) agents, methotrexate, or other non-biological disease-modifying antirheumatic drugs (DMARDs) on cardiovascular event risks among patients with rheumatoid arthritis (RA). METHODS: We conducted a retrospective study us...

Descripción completa

Detalles Bibliográficos
Autores principales: Nurmohamed, Michael, Bao, Yanjun, Signorovitch, James, Trahey, Alex, Mulani, Parvez, Furst, Daniel E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612693/
https://www.ncbi.nlm.nih.gov/pubmed/26535138
http://dx.doi.org/10.1136/rmdopen-2015-000080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612693/
https://www.ncbi.nlm.nih.gov/pubmed/26535138
http://dx.doi.org/10.1136/rmdopen-2015-000080

Ejemplares similares